Figures & data
Figure 1 Rates of hypofractionation and RT omission for the years 2006–2008 and 2011–2013. WBRT hypofractionation rates are for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer. RT omission rates are for patients aged >70 years. Rates at our NCCN-member institution are compared to national rates per Bekelman et alCitation24 and Palta et al.Citation25P<0.001 for statistical difference between the 2006–2008 and 2011–2013 institution-specific hypofractionation rates. P=0.11 for statistical difference between the 2006–2008 and 2011–2013 institution-specific RT omission rates.
![Figure 1 Rates of hypofractionation and RT omission for the years 2006–2008 and 2011–2013. WBRT hypofractionation rates are for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer. RT omission rates are for patients aged >70 years. Rates at our NCCN-member institution are compared to national rates per Bekelman et alCitation24 and Palta et al.Citation25P<0.001 for statistical difference between the 2006–2008 and 2011–2013 institution-specific hypofractionation rates. P=0.11 for statistical difference between the 2006–2008 and 2011–2013 institution-specific RT omission rates.](/cms/asset/55f73559-a793-48d7-8e1c-b3da5bb72d4a/dbct_a_29445299_f0001_b.jpg)
Table 1 RT practice patterns for patients aged ≥50 years with hormone receptor-positive, early-stage breast cancer at our NCCN-member institution
Table 2 Direct medical cost for whole-breast radiotherapy